Technology
BIT Mining Limited Announces Unaudited Financial Results for the Fourth Quarter and Full Year ended December 31, 2023
Published
3 years agoon
By
AKRON, Ohio, Feb. 23, 2024 /PRNewswire/ — BIT Mining Limited (NYSE: BTCM) (“BIT Mining,” “the Company,” “we,” “us,” or “our company”), a leading technology-driven cryptocurrency mining company, today reported its unaudited financial results for the fourth quarter ended December 31, 2023.
On December 28, 2023, the Company entered into an agreement with Esport – Win Limited, a Hong Kong limited liability company, to sell its entire mining pool business for a total consideration of US$5 million. The sale does not include or affect any of BIT Mining’s other businesses. The disposal of the mining pool business represents a strategic shift and has a major effect on the Company’s results of operations. Accordingly, the Company’s consolidated financial statements for the period ended December 31, 2023 and the comparable periods have been reclassified to reflect the mining pool business segment as discontinued operations.
Fourth Quarter 2023 Highlights for Continuing Operations
Revenues were US$10.4 million for the fourth quarter of 2023, representing an increase of US$3.2 million from US$7.2 million for the fourth quarter of 2022, and a decrease of US$1.2 million from US$11.6 million for the third quarter of 2023.Operating loss was US$1.6 million for the fourth quarter of 2023, representing a significant decrease of US$36.7 million from US$38.3 million for the fourth quarter of 2022, and a decrease of US$2.5 million from US$4.1 million for the third quarter of 2023.Non-GAAP operating loss1 was US$1.3 million for the fourth quarter of 2023, compared with non-GAAP operating loss of US$15.7 million for the fourth quarter of 2022, and non-GAAP operating loss of US$4.1 million for the third quarter of 2023.Net loss attributable to BIT Mining was US$0.8 million for the fourth quarter of 2023, compared with net loss attributable to BIT Mining of US$40.0 million for the fourth quarter of 2022, and net loss attributable to BIT Mining of US$4.7 million for the third quarter of 2023.Non-GAAP net loss1 attributable to BIT Mining was US$0.9 million for the fourth quarter of 2023, compared with non-GAAP net loss attributable to BIT Mining of US$15.1 million for the fourth quarter of 2022, and non-GAAP net loss attributable to BIT Mining of US$3.9 million for the third quarter of 2023.Basic and diluted losses per American Depositary Share (“ADS”)2 attributable to BIT Mining Limited including from continuing operations and discontinued operations for the fourth quarter of 2023 were US$0.38.Non-GAAP basic and diluted losses per ADS2 attributable to BIT Mining Limited including from continuing operations and discontinued operations for the fourth quarter of 2023 were US$0.39.
Full Year 2023 Highlights for Continuing Operations
Revenues were US$43.1 million for the full year 2023, compared with revenues of US$57.0 million for the full year 2022.Operating loss was US$12.9 million for the full year 2023, compared with operating loss of US$88.1 million for the full year 2022.Non-GAAP operating loss1 was US$11.9 million for the full year 2023, compared with non-GAAP operating loss of US$42.1 million for the full year 2022.Net loss attributable to BIT Mining was US$11.1 million for the full year 2023, compared with net loss attributable to BIT Mining of US$74.8 million for the full year 2022.Non-GAAP net loss1 attributable to BIT Mining was US$9.9 million for the full year 2023, compared with non-GAAP net loss attributable to BIT Mining of US$26.6 million for the full year 2022.Basic and diluted losses per ADS2 attributable to BIT Mining Limited including from continuing operations and discontinued operations for the full year 2023 were US$1.31.Non-GAAP basic and diluted losses per ADS2 attributable to BIT Mining Limited including from continuing operations and discontinued operations for the full year 2023 were US$1.21.
Full Year 2023 Highlights for Discontinued Operations
Net loss from discontinued operations, net of taxes was US$3.4 million for the full year 2023, compared with net loss from discontinued operations, net of taxes of US$80.6 million for the full year 2022. The year-over-year decrease of US$77.2 million was mainly attributable to the impairment of intangible assets in the amount of US$48.6 million and impairment of goodwill in the amount of US$26.6 million in the year of 2022 associated with the discontinued operations.
1 Non-GAAP financial measures exclude the impact of share-based compensation expenses, impairment of intangible assets, impairment of property and equipment, impairment of equity investments, changes in fair value of contingent considerations, and changes in fair value of derivative instruments. Reconciliations of non-GAAP financial measures to U.S. GAAP financial measures are set forth in the table at the end of this release.
2 The Company changed the ratio of ADSs to its Class A ordinary shares (the “ADS Ratio”), par value US$0.00005 per share, from the former ADS Ratio of one (1) ADS to ten (10) Class A ordinary shares, to the current ADS Ratio of one (1) ADS to one hundred (100) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change was effective on December 23, 2022.
Fourth Quarter 2023 Financial Results for Continuing Operations
Revenues
Revenues were mainly comprised of US$4.7 million from the self-mining business and US$5.7 million from the data center business.
Self-mining
As of today, the total hash rate capacity of our DOGE/LTC mining machines in operation is approximately 24,766.0 GH/s. For the three months ended December 31, 2023, we produced 38.3 million DOGE and 10,615 LTC from our DOGE/LTC cryptocurrency mining operations and recognized revenue of approximately US$3.6 million.
Considerable uncertainty persists in the market despite the recent modest recovery and narrow growth in cryptocurrency asset prices. Facing this current environment, we remain determined to improve our quality and efficiency. As of today, the total hash rate capacity of our BTC mining machines in operation is approximately 56.63 PH/s. For the three months ended December 31, 2023, we produced 21 BTC from our BTC cryptocurrency mining operations and recognized revenue of approximately US$0.8 million. We also recognized revenue of approximately US$0.3 million from our ETC cryptocurrency mining operations.
Data Center Operation
During the fourth quarter of 2023, our 82.5 megawatt space (the “82.5 Megawatt Space”) at the Ohio Mining Site recognized approximately $5.7 million in service fee revenue, representing a decrease of US$0.7 million compared with the third quarter of 2023, primarily due to one of our customers entered into arrangement directly with the utility service provider. As a result, our service fee revenue from the customer decreased during the fourth quarter of 2023.
Overall
Revenues were US$10.4 million for the fourth quarter of 2023, representing an increase of US$3.2 million, or 44.4%, from US$7.2 million for the fourth quarter of 2022, and a decrease of US$1.2 million, or 10.3%, from US$11.6 million for the third quarter of 2023. The year-over-year increase was mainly attributable to an increase of US$3.6 million in the DOGE/LTC cryptocurrency production, due to an increase in hash power related to new mining machines that were put into operation in 2023. The sequential decrease was mainly attributable to higher computing power of the whole network in the fourth quarter of 2023 compared with the computing power in the third quarter of 2023, resulting in an increased difficulty in cryptocurrency mining activities.
Operating Costs and Expenses
Operating costs and expenses were US$13.2 million for the fourth quarter of 2023, representing a decrease of US$9.7 million, or 42.4%, from US$22.9 million for the fourth quarter of 2022, and a decrease of US$1.8 million, or 12.0%, from US$15.0 million for the third quarter of 2023.
Cost of revenue was US$8.9 million for the fourth quarter of 2023, representing a decrease of US$7.5 million, or 45.7%, from US$16.4 million for the fourth quarter of 2022, and a decrease of US$1.9 million, or 17.6%, from US$10.8 million for the third quarter of 2023. The sequential decrease was mainly attributable to the decrease in electricity fees payable to the utility service provider as one of our customers entered into arrangement directly with the utility service provider. The year-over-year decrease was mainly attributable to the decrease in electricity fees payable mentioned above, and the overall year-over-year decrease in electricity rates charged by the utility service provider. Cost of revenue was comprised of the direct cost of revenue of US$6.0 million and depreciation and amortization of US$2.9 million. The direct cost of revenue mainly included direct costs relating to (i) the cryptocurrency mining business of US$1.3 million, and (ii) the data center business of US$4.7 million.
Sales and marketing expenses were US$0.3 million for the fourth quarter of 2023, compared with US$0.03 million for the fourth quarter of 2022 and US$0.03 million for the third quarter of 2023.
General and administrative expenses were US$4.1 million for the fourth quarter of 2023, representing a decrease of US$1.9 million, or 31.7%, from US$6.0 million for the fourth quarter of 2022 and a slight decrease of US$0.1 million, or 2.4%, from US$4.2 million for the third quarter of 2023. The year-over-year decrease was mainly due to a decrease of US$1.0 million in technical service fee.
Service development expenses were nil for the fourth quarter of 2023, compared with US$0.5 million for the fourth quarter of 2022 and US$0.04 million for the third quarter of 2023. The year-over-year decrease was mainly due to a decrease in staff costs, benefits, share-based compensation and other related expenses as a result of a decrease in headcount.
Net Gain on Disposal of Cryptocurrency Assets
Net gain on disposal of cryptocurrency assets was US$1.5 million for the fourth quarter of 2023, representing a decrease of US$2.2 million from US$3.7 million for the fourth quarter of 2022, and an increase of US$0.6 million from US$0.9 million for the third quarter of 2023, by using the first-in-first-out (“FIFO”) method to calculate the cost of disposition during the fourth quarter of 2023.
Impairment of Cryptocurrency Assets
Impairment of cryptocurrency assets was US$0.2 million for the fourth quarter of 2023, representing a decrease of US$1.9 million from US$2.1 million for the fourth quarter of 2022, and a decrease of US$0.5 million from US$0.7 million for the third quarter of 2023, mainly due to less provision recorded for impairment of cryptocurrency assets held as a result of generally increasing cryptocurrency prices.
Impairment of Property and Equipment
Impairment of property and equipment was nil for the third and fourth quarters of 2023 and was US$22.6 million for the fourth quarter of 2022, which was mainly due to the provision for impairment of mining machines in Kazakhstan and the U.S.
Operating Loss from continuing operations
Operating loss from continuing operations was US$1.6 million for the fourth quarter of 2023, compared with operating loss from continuing operations of US$38.3 million for the fourth quarter of 2022, and operating loss from continuing operations of US$4.1 million for the third quarter of 2023.
Non-GAAP operating loss from continuing operations was US$1.3 million for the fourth quarter of 2023, compared with non-GAAP operating loss from continuing operations of US$15.7 million for the fourth quarter of 2022, and non-GAAP operating loss from continuing operations of US$4.1 million for the third quarter of 2023. The year-over-year decrease in non-GAAP operating loss from continuing operations was mainly due to (i) an increase of US$2.8 million in revenue of the self-mining business, due to increases in cryptocurrency prices and mining machine, (ii) a decrease of US$1.9 million in impairment of cryptocurrency assets, (iii) a decrease of US$4.4 million in depreciation and amortization expenses due to impairment of mining machines and intangible asset in 2022, and (iv) a decrease of US$1.2 million in cloud computing power rental costs. The sequential decrease in non-GAAP operating loss from continuing operations was mainly due to (i) a decrease of US$0.5 million in impairment of cryptocurrency assets and an increase of US$0.6 million in net gain on disposal of cryptocurrency assets resulting from increases in cryptocurrency prices, and (ii) a decrease of US$0.8 million in other operating expenses.
Net Loss Attributable to BIT Mining including from continuing operations and discontinued operations
Net loss attributable to BIT Mining was US$4.2 million for the fourth quarter of 2023, compared with net loss attributable to BIT Mining of US$109.2 million for the fourth quarter of 2022, and net loss attributable to BIT Mining of US$4.4 million for the third quarter of 2023. The year-over-year decrease in net loss attributable to BIT Mining was mainly due to (i) a decrease of US$22.6 million in impairment of property and equipment, (ii) decrease in net loss from discontinued operations resulting from a decrease of US$48.6 million in impairment of intangible assets and a decrease of US$26.6 million in impairment of goodwill, and (iii) a decrease of US$2.3 million in impairment of long-term investments.
Non-GAAP net loss attributable to BIT Mining was US$4.4 million for the fourth quarter of 2023, compared with non-GAAP net loss attributable to BIT Mining of US$9.1 million for the fourth quarter of 2022, and non-GAAP net loss attributable to BIT Mining of US$3.6 million for the third quarter of 2023. The year-over-year decrease in non-GAAP net loss attributable to BIT Mining was mainly due to the reasons related to the decrease in net loss from discontinued operations mentioned above. The sequential increase in non-GAAP net loss attributable to BIT Mining was mainly due to the increase in net loss from discontinued operations of US$3.8 million.
Cash and Cash Equivalents, Restricted Cash and Short-term Investment
As of December 31, 2023, the Company had cash and cash equivalents of US$3.6 million, compared with cash and cash equivalents of US$5.4 million, restricted cash3 of US$0.1 million, and short-term investment4 of US$2.4 million as of December 31, 2022.
Cryptocurrency Assets
As of December 31, 2023, the Company had cryptocurrency assets of US$7.6 million in aggregate, which comprised of 22.6 BTC, 12.2 million DOGE, 11,955 LTC, and various other cryptocurrency assets, which were generated from its cryptocurrency mining businesses, without regard to its mining pool businesses.
3 Restricted cash represents deposits in merchant banks yet to be withdrawn.
4 Short-term investment represents fixed coupon notes with original maturities of greater than three months but less than a year.
About BIT Mining Limited
BIT Mining (NYSE: BTCM) is a leading technology-driven cryptocurrency mining company with operations in cryptocurrency mining, data center operation and mining machine manufacturing. The Company is strategically creating long-term value across the industry with its cryptocurrency ecosystem. Anchored by its cost-efficient data centers that strengthen its profitability with steady cash flow, the Company also conducts self-mining operations that enhance its marketplace resilience by leveraging self-developed and purchased mining machines to seamlessly adapt to dynamic cryptocurrency pricing. The Company also owns 7-nanometer BTC chips and has strong capabilities in the development of LTC/DOGE miners and ETC miners.
Safe Harbor Statements
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates”, “target”, “going forward”, “outlook” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
About Non-GAAP Financial Measures
As a supplement to net loss, we use the non-GAAP financial measure of adjusted net loss which is U.S. GAAP net loss as adjusted to exclude the impact of share-based compensation expenses, impairment of intangible assets, impairment of equity investments, impairment of property and equipment, changes in fair value of contingent considerations, and changes in fair value of derivative instruments. All adjustments are non-cash and we believe they are not reflective of our general business performance. This non-GAAP financial measure is provided as additional information to help our investors compare business trends among different reporting periods on a consistent basis and to enhance investors’ overall understanding of our current financial performance and prospects for the future. This non-GAAP financial measure should not be considered in addition to or as a substitute for or superior to U.S. GAAP net loss. In addition, our definition of adjusted net loss may be different from the definition of such term used by other companies, and therefore comparability may be limited.
For more information:
BIT Mining Limited
ir@btcm.group
ir.btcm.group
www.btcm.group
Piacente Financial Communications
Brandi Piacente
Tel: +1 (212) 481-2050
Email: BITMining@thepiacentegroup.com
BIT Mining Limited
Condensed Consolidated Balance Sheets
(Amounts in thousands of U.S. dollars (“US$”), except for number of shares)
(Unaudited)
December 31, 2022
December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents
5,371
3,575
Restricted cash
126
–
Short-term investment
2,360
–
Accounts receivable
3,575
2,873
Prepayments and other current assets
8,310
12,723
Cryptocurrency assets
5,573
7,629
Current assets of discontinued operations
10,021
13,712
Total current assets
35,336
40,512
Non-current assets:
Property and equipment, net
27,209
22,833
Intangible assets, net
3,299
2,033
Deposits
2,387
2,467
Long-term investments
8,049
6,307
Right-of-use assets
4,135
3,752
Long-term prepayments and other non-current assets
6,363
47
Non-current assets of discontinued operations
26
–
Total non-current assets
51,468
37,439
TOTAL ASSETS
86,804
77,951
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
3,672
2,291
Accrued payroll and welfare payable
747
458
Accrued expenses and other current liabilities
4,825
4,335
Income tax payable
73
76
Operating lease liabilities – current
1,367
1,413
Current liabilities of discontinued operations
20,155
27,605
Total current liabilities
30,839
36,178
Non-current liabilities:
Operating lease liabilities – non-current
2,837
2,339
Total non-current liabilities
2,837
2,339
TOTAL LIABILITIES
33,676
38,517
Shareholders’ equity:
Class A ordinary shares, par value US$0.00005 per share;
1,599,935,000 shares authorized as of December 31, 2022 and
December 31, 2023; 1,063,813,210 and 1,111,232,210 shares issued
and outstanding as of December 31, 2022 and December 31, 2023,
respectively
54
54
Class A preference shares, par value US$0.00005 per share; 65,000
shares authorized as of December 31, 2022 and December 31, 2023;
65,000 shares issued and outstanding as of December 31, 2022
and December 31, 2023
–
–
Class B ordinary shares, par value US$0.00005 per share; 400,000,000
shares authorized as of December 31, 2022 and December 31, 2023;
99 shares issued and outstanding as of December 31, 2022 and
December 31, 2023
–
–
Additional paid-in capital
620,807
621,837
Treasury shares
(21,604)
(21,604)
Accumulated deficit and statutory reserve
(542,169)
(556,597)
Accumulated other comprehensive loss
(3,960)
(4,256)
Total shareholders’ equity
53,128
39,434
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
86,804
77,951
BIT Mining Limited
Condensed Consolidated Statements of Comprehensive Loss
(Amounts in thousands of U.S. dollars (“US$”),
except for number of shares, per share (or ADS) data)
(Unaudited)
Three Months Ended
Twelve Months Ended
December 31,
2022
September 30,
2023
December 31,
2023
December 31,
2022
December 31,
2023
Revenues
7,168
11,639
10,407
57,025
43,101
Operating costs and
expenses:
Cost of revenue
(16,417)
(10,763)
(8,935)
(61,195)
(39,147)
Sales and marketing
expenses
(27)
(33)
(256)
(336)
(378)
General and
administrative expenses
(5,951)
(4,184)
(4,054)
(21,946)
(19,153)
Service development
expenses
(481)
(38)
–
(2,213)
(874)
Total operating costs
and expenses
(22,876)
(15,018)
(13,245)
(85,690)
(59,552)
Other operating income
135
–
86
115
220
Government grant
2
–
–
29
–
Other operating
expenses
(1,750)
(995)
(197)
(3,234)
(1,494)
Net gain (loss) on
disposal of
cryptocurrency assets
3,711
932
1,531
(5,384)
7,074
Impairment of
cryptocurrency assets
(2,097)
(691)
(163)
(9,396)
(2,280)
Changes in fair value of
contingent
considerations
–
–
–
1,247
–
Impairment of property
and equipment
(22,641)
–
–
(35,224)
–
Impairment of
intangible assets
–
–
–
(7,539)
–
Operating loss
(38,348)
(4,133)
(1,581)
(88,051)
(12,931)
Other income
(expense), net
531
(5)
395
9,031
797
Interest income
25
200
–
150
242
Interest expense
–
–
–
(218)
–
Gain from equity
method investments
8
–
–
164
939
Impairment of long-
term investments
(2,250)
–
–
(2,250)
–
Gain from disposal of
subsidiaries
–
–
–
3,340
–
Changes in fair value of
derivative instruments
–
(808)
423
–
(110)
Loss before income tax
from continuing
operations
(40,034)
(4,746)
(763)
(77,834)
(11,063)
Income tax benefits
–
–
–
–
–
Net loss from continuing
operations
(40,034)
(4,746)
(763)
(77,834)
(11,063)
Net (loss) income from
discontinued
operations, net of
applicable income taxes
(69,123)
387
(3,455)
(80,593)
(3,365)
Net loss
(109,157)
(4,359)
(4,218)
(158,427)
(14,428)
Less: Net loss
attributable to
noncontrolling interests
–
–
–
(3,012)
–
Net loss attributable to
BIT Mining Limited
(109,157)
(4,359)
(4,218)
(155,415)
(14,428)
Other comprehensive
income (loss):
Foreign currency
translation gain (loss)
236
(44)
188
(1,735)
(296)
Other comprehensive
income (loss), net of tax
236
(44)
188
(1,735)
(296)
Comprehensive loss
(108,921)
(4,403)
(4,030)
(160,162)
(14,724)
Less: comprehensive
loss attributable to
noncontrolling interests
–
–
–
(3,142)
–
Comprehensive loss
attributable to BIT
Mining Limited
(108,921)
(4,403)
(4,030)
(157,020)
(14,724)
Weighted average
number of Class A and
Class B ordinary shares
outstanding:
Basic
1,063,813,210
1,111,232,309
1,111,232,309
871,036,499
1,102,373,814
Diluted
1,063,813,210
1,111,232,309
1,111,232,309
871,036,499
1,102,373,814
Losses per share
attributable to BIT
Mining Limited-Basic
and Diluted
Net loss from
continuing operations
(0.04)
(0.00)
(0.00)
(0.09)
(0.01)
Net (loss) income from
discontinued operations
(0.06)
0.00
(0.00)
(0.09)
(0.00)
Net loss
(0.10)
(0.00)
(0.00)
(0.18)
(0.01)
Losses per ADS*
attributable to BIT
Mining Limited-Basic
and Diluted
Net loss from
continuing operations
(3.76)
(0.43)
(0.07)
(8.59)
(1.00)
Net (loss) income from
discontinued operations
(6.50)
0.04
(0.31)
(9.25)
(0.31)
Net loss
(10.26)
(0.39)
(0.38)
(17.84)
(1.31)
* American Depositary Shares, which are traded on the NYSE. Each ADS represents ten Class A ordinary shares of the Company.
BIT Mining Limited
Reconciliation of non-GAAP results of operations measures to the nearest comparable GAAP measures
(Amounts in thousands of U.S. dollars (“US$”),
except for number of shares, per share (or ADS) data)
(Unaudited)
Three Months Ended
Twelve Months Ended
December 31,
2022
September 30,
2023
December 31,
2023
December 31,
2022
December 31,
2023
Operating loss from continuing operations
(38,348)
(4,133)
(1,581)
(88,051)
(12,931)
Adjustment for share-based compensation
expenses
–
–
276
4,474
1,030
Adjustment for impairment of intangible assets
–
–
–
7,539
–
Adjustment for impairment of property and
equipment
22,641
–
–
35,224
–
Adjustment for changes in fair value of contingent
considerations
–
–
–
(1,247)
–
Adjusted operating loss (non-GAAP) from
continuing operations
(15,707)
(4,133)
(1,305)
(42,061)
(11,901)
Net loss attributable to BIT Mining Limited
(109,157)
(4,359)
(4,218)
(155,415)
(14,428)
Net (loss) income attributable to BIT Mining
Limited
from discontinued operations, net of applicable
income taxes
(69,123)
387
(3,455)
(80,593)
(3,365)
Net loss attributable to BIT Mining Limited
from continuing operations
(40,034)
(4,746)
(763)
(74,822)
(11,063)
Adjustment for share-based compensation
expenses
–
–
276
4,474
1,030
Adjustment for impairment of intangible
assets
–
–
–
7,539
–
Adjustment for impairment of equity
investments
2,250
–
–
2,250
–
Adjustment for impairment of property
and equipment
22,641
–
–
35,224
–
Adjustment for changes in fair value of
derivative instruments
–
808
(423)
–
110
Adjustment for changes in fair value of
contingent considerations
–
–
–
(1,247)
–
Adjusted net loss attributable to BIT Mining
Limited (non-GAAP) from continuing operations
(15,143)
(3,938)
(910)
(26,582)
(9,923)
Net loss from discontinued operations, net of
applicable income taxes
(69,123)
387
(3,455)
(80,593)
(3,365)
Adjustment for impairment of intangible assets
48,555
–
–
48,555
–
Adjustment for impairment of goodwill
26,569
–
–
26,569
–
Adjusted net income (loss) attributable to BIT
Mining Limited (non-GAAP) from discontinued
operations
6,001
387
(3,455)
(5,469)
(3,365)
Adjusted net loss attributable to BIT Mining
Limited (non-GAAP)
(9,142)
(3,551)
(4,365)
(32,051)
(13,288)
Weighted average number of Class A and
Class B ordinary shares outstanding:
Basic
1,063,813,210
1,111,232,309
1,111,232,309
871,036,499
1,102,378,814
Diluted
1,063,813,210
1,111,232,309
1,111,232,309
871,036,499
1,102,373,814
Losses per share attributable to BIT Mining
Limited (non-GAAP)-Basic and Diluted
Adjusted net loss from continuing operations
(non-GAAP)
(0.01)
(0.00)
(0.00)
(0.03)
(0.01)
Adjusted net (loss) income from discontinued operations
(non-GAAP)
0.00
0.00
(0.00)
(0.01)
(0.00)
Adjusted net loss (non-GAAP)
(0.01)
(0.00)
(0.00)
(0.04)
(0.01)
Losses per ADS* attributable to BIT Mining
Limited (non-GAAP)-Basic and Diluted (Note)
Adjusted net loss from continuing operations (non-GAAP)
(1.42)
(0.35)
(0.08)
(3.05)
(0.90)
Adjusted net (loss) income from discontinued operations
(non-GAAP)
0.56
0.03
(0.31)
(0.63)
(0.31)
Adjusted net loss (non-GAAP)
(0.86)
(0.32)
(0.39)
(3.68)
(1.21)
* American Depositary Shares, which are traded on the NYSE. Each ADS represents 100 Class A ordinary shares of the Company.
View original content:https://www.prnewswire.com/news-releases/bit-mining-limited-announces-unaudited-financial-results-for-the-fourth-quarter-and-full-year-ended-december-31-2023-302070108.html
SOURCE BIT Mining Limited
You may like
Technology
Vertical IQ Will Expand Industry Intelligence Platform with Small Business Financial Exchange (SBFE) Small Business Credit Data
Published
26 minutes agoon
October 27, 2026By
RALEIGH, N.C., Oct. 27, 2026 /PRNewswire/ — Small Business Financial Exchange (SBFE), the trusted source for small business lending data and Vertical IQ, a nationally recognized provider of Industry Intelligence, today announced their partnership. Through the partnership, Vertical IQ will incorporate SBFE small business credit insights into its platform, providing financial institutions with deeper context to support commercial lending decisions.
The collaboration enables banks, credit unions, and other commercial lenders using Vertical IQ to gain access to SBFE small business credit insights within the Industry Intelligence platform. Default rates, delinquencies, and credit trends by industries are just a few of the SBFE features that will be included. These insights allow financial services professionals to better understand small business borrowers and support key commercial lending activities.
“At SBFE, we’re committed to helping lenders better understand and support small businesses. Extending access to SBFE insights through Vertical IQ is another way we can deliver value to the lending community and support greater access to capital.”
– Elisabeth MacDonald, President and CEO, SBFE
“At Vertical IQ, we believe financial institutions make their best decisions when they have access to trusted, Verified Industry Intelligence powered by the highest-quality data available,” said Bobby Martin, co-founder and CEO of Vertical IQ. “Our partnership with SBFE represents another important step in that commitment by bringing highly respected small business credit insights into our platform. By combining SBFE’s credit data with Vertical IQ’s industry expertise, we’re helping lenders gain deeper context to strengthen credit analysis, improve risk assessment, and make more confident decisions throughout the commercial lending lifecycle.”
– Bobby Martin, Co-founder and CEO, Vertical IQ
About SBFE
SBFE is the trusted data exchange where the small business lending industry comes together to strengthen access to capital for America’s small businesses. For more than 25 years, SBFE has united lenders in a member-driven community built on trust, collaboration, and the responsible use of data. Today, SBFE securely manages one of the nation’s largest repositories of small business credit data, contributed by more than 140 member institutions, including many of the country’s largest commercial banks. This data enables highly predictive credit reporting and portfolio management solutions that help lenders make more informed decisions, manage risk, and support the financial health and growth of small businesses. By transforming shared data into trusted lending intelligence, SBFE helps its members strengthen credit decisioning and promote greater access to capital. Learn more at www.SBFE.org
About Vertical IQ
Headquartered in Raleigh, North Carolina, Vertical IQ is a nationally recognized provider of Industry Intelligence. Whether discussing cash management with a local brewery or evaluating risk for a large manufacturing company, successful banks, credit unions, accounting firms, insurance organizations, and advisory firms use Vertical IQ to better understand a prospect’s or client’s business challenges before, during, and after meetings. Covering 100% of the industries that comprise the U.S. and Canadian economies, as well as more than 3,400 local economic reports, Vertical IQ equips professionals with the confidence and credibility to build stronger client relationships and make more informed decisions. Learn more at www.verticaliq.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vertical-iq-will-expand-industry-intelligence-platform-with-small-business-financial-exchange-sbfe-small-business-credit-data-302920872.html
SOURCE SBFE
Technology
CME Group Brazilian Real Futures Set New Daily Volume Record Following Election
Published
26 minutes agoon
October 27, 2026By
Record $9 billion notional traded, eleven times the year-to-date average daily volume (ADV) as market participants turned to CME Group to manage risk around the clock
CHICAGO, Oct. 27, 2026 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that its Brazilian real (BRL) futures reached a new daily volume record of 498,498 contracts (R$49.8 billion, ~$9.2 billion notional value) on October 26, surpassing the previous record of 191,325 contracts (~$3.7 billion notional value) traded on September 28, 2026.
“Following the results of the Brazilian presidential election, clients turned to our BRL futures market to immediately manage their risk outside of Brazilian trading hours, driving all-time record volume,” said Paul Houston, Global Head of FX Products, CME Group. “Even before the onshore market opened, $2.5 billion in notional value had already traded, roughly three times the year-to-date ADV for BRL futures. With liquidity in all timezones and contracts denominated in USD, our markets are fast becoming the main venue for Brazilian real price discovery and trading outside of onshore hours, giving global participants the liquidity they need around the clock.”
In the first half of 2026, Mexican peso and Brazilian real futures and options saw a record combined average daily volume of $2.94 billion.
For more information on CME Group BRL futures, please visit https://www.cmegroup.com/articles/faqs/latam-fx-futures-frequently-asked-questions.html
As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.
CME-G
View original content to download multimedia:https://www.prnewswire.com/news-releases/cme-group-brazilian-real-futures-set-new-daily-volume-record-following-election-302920902.html
SOURCE CME Group
Technology
Vera Health Quietly Became One of the World’s Most Used Clinical Tools. Now It Has Raised $32 Million to Give Every Clinician in the World the Best Medical Knowledge in Seconds
Published
26 minutes agoon
October 27, 2026By
With a team of just 12 employees, the clinical AI company has grown largely through physician referrals, bringing total funding to $32 million
More than 800,000 clinicians across 190 countries use Vera Health, including approximately 1 in 4 physicians in Spain and Italy, with most discovering the platform through recommendations from colleagues.Threshold Ventures led Vera Health’s $28.5 million Series A, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient tripled down, bringing total funding to $32 million.The investment will accelerate Vera Health’s evidence-focused clinical AI platform, expanding its ability to make global medical knowledge locally relevant and deepening partnerships with medical societies, publishers and health systems.
SAN FRANCISCO, Oct. 27, 2026 /PRNewswire/ — A year ago, a few thousand clinicians were using Vera Health. Today, more than 800,000 are, most having discovered the platform through a colleague. Every month since June, Vera has been the most downloaded clinical app in the world across the App Store and Google Play.¹ In September alone, it was downloaded more times than OpenEvidence and Doximity combined, while monthly downloads had more than tripled since February. With a team of just 12 employees, Vera has reached clinicians in 190 countries, including approximately 1 in 4 physicians in Spain and Italy, largely through word of mouth. Vera Health is a clinical AI search engine that reasons like a clinician, helping physicians find and evaluate medical evidence in seconds.
Today, Vera Health announced a $28.5 million Series A led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient, tripled down in the round, bringing the company’s total funding to $32 million. The investment will accelerate Vera Health’s mission to close the gap between what medicine knows and what every patient receives.
Only a few months after raising its Series A, Vera already has more daily active users than it had monthly active users at the time of the raise. Clinicians went from asking Vera a few thousand questions a day to asking hundreds of thousands, every single day.
“Clinicians are the best data scientists I’ve ever met. They make the call in seconds, with more evidence than any human could ever read,” said Taieb Bennani, Co-Founder of Vera Health. “The secret to building for them is to live and breathe the problem like no one else. Everyone on our team is a clinician, or the child or sibling of one, like Maxime and me. That passion translates into every detail of the product, and when you build with that kind of obsession, the product speaks for itself, and clinicians share it with their colleagues. We don’t have the biggest team or the most money. We have the people who care the most about getting it right.”
How does Vera Health differ from general-purpose AI tools?
Clinical AI is increasingly being used to help physicians navigate complex medical questions, but the ability to generate an accurate-sounding answer does not necessarily establish whether the underlying research is reliable. Medicine now publishes a new scientific paper roughly every 20 seconds. Chatbots are built to sound confident. Vera is built to be accurate, and honest when the evidence is thin. Physicians are expected to keep up with an expanding body of research while interpreting guidelines, evaluating treatment options and making decisions for individual patients, sometimes within seconds.
Vera Health finds the evidence first, then writes the answer. Its technology searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, evaluating sources based on study design, level of evidence, cohort size, recency, journal quality and citation impact. Every claim is linked to its supporting research and color-coded to show the strength of the available evidence. Sometimes that color is red. A rare condition may have no large randomized trial or comprehensive guideline behind it, leaving only a small case series or a report involving a single patient. Vera Health surfaces that research while making its limitations visible, allowing physicians to assess how much weight the findings deserve.
“Medical knowledge moves too quickly for any one clinician to read, and general-purpose AI tools can make uncertain evidence sound settled,” said Maxime Allouch, co-founder, Vera Health. “Unlike other tools, we believe there’s value in making uncertainty visible. The grade shapes what Vera retrieves and writes, while the clinician brings the patient, the context and the judgment.”
Vera Health developed its approach alongside physicians who evaluate medical evidence and help write the guidelines other clinicians follow. Through its partnership with the American College of Emergency Physicians (ACEP), the platform integrates ACEP clinical policies with source attribution, bringing medical society guidance directly into clinical research workflows.
“In medicine, not all evidence is equal,” said Scott M. Silvers, MD, FACEP, Chair of the American College of Emergency Physicians’ Clinical Policies Committee and former Chair of Emergency Medicine at Mayo Clinic. “A large, randomized trial and a case report should never carry the same weight, yet most AI tools blend them into the same confident answer. Level of evidence is the foundation of every guideline we write, and Vera Health is built on it.”
For Dr. Bernard P. Chang, Vera Health’s Chief Scientific Advisor and Vice Chair of Research in the Department of Emergency Medicine at Columbia University, the importance of clinical evidence extends to how physicians evaluate patients.
“On a recent emergency-department shift, I saw a young woman with cough and shortness of breath. The symptoms could easily be attributed to a routine respiratory illness,” said Chang. “Vera Health surfaced evidence that raised my concern for pulmonary embolism, a potentially life-threatening blood clot in the lungs, and led me to broaden my evaluation. What interests me isn’t AI simply providing an answer. It’s whether it can reliably surface evidence that challenges our initial assumptions and improves clinical reasoning. That’s what we’re now evaluating rigorously, inside the academic medical centers where medicine is actually practiced.”
Vera Health’s clinical advisors also include Christopher Baugh, MD, MBA, FACEP, Vice Chair of Clinical Affairs in Emergency Medicine at Brigham and Women’s Hospital and Associate Professor of Emergency Medicine at Harvard Medical School. Its clinical council includes physician leaders affiliated with Mayo Clinic, Yale, Harvard, Columbia and Penn.
Why is Vera Health growing so quickly across international markets?
Bennani and Allouch grew up in families of physicians and initially developed Vera Health for their own fathers. What began with two users has since grown into a platform serving hundreds of thousands of clinicians, with physicians asking hundreds of thousands of questions each day. The company’s international growth reflects an approach built around a central reality of medicine. Medical knowledge is global, but clinical practice is local.
An emergency physician in France may follow different treatment guidelines than a physician in the United States. An oncologist reviewing a complex case may need an exhaustive evaluation of the available research, while an emergency physician needs a concise answer within seconds. Even physicians practicing the same specialty may follow different protocols depending on their institution.
Vera Health accounts for those differences by prioritizing locally relevant guidance while drawing on medical research from around the world. Through Vera Spaces, health systems can also integrate their own clinical protocols and pathways alongside national guidelines and international medical literature.
“Medicine is global, yet most tools in our space were built for a single geography,” said Allouch. “We went international from day one, because only a global view reveals what is truly local.”
The approach has helped Vera Health expand across Europe, where approximately 1 in 4 physicians in Spain and Italy and 1 in 7 in France use the platform, according to company data. Vera Health has achieved that international reach with a small team and a product that clinicians have largely discovered through their peers.
What will Vera Health’s Series A funding support next?
The financing will support further development of Vera Health’s clinical evidence infrastructure, expansion into additional healthcare markets and deeper partnerships with medical societies, publishers and health systems. The company will continue investing in locally relevant clinical guidance and tools that allow healthcare institutions to incorporate their own medical knowledge into the platform.
“In healthcare, trust is earned, not bought. Vera’s adoption among clinicians worldwide speaks to what Taieb and Maxime have built. By combining the most rigorous medical evidence with an understanding of each physician’s specialty, protocols and practice context, Vera makes the world’s medical knowledge relevant to how care is actually delivered. We believe that creates an enormous opportunity to improve global health,” said Andrew Brackin, Partner at Gradient.
“Vera is compelling because it starts with the evidence, not just an answer—helping clinicians find and assess the research behind a decision while making its strengths and limitations visible. By bringing that evidence to the point of care, Vera becomes a trusted clinical intelligence layer, not just another AI tool,” said Emily Melton, co-founder and managing partner of Threshold Ventures.
Vera Health will remain free for licensed clinicians and medical trainees worldwide as it expands access to medical evidence and locally relevant clinical guidance.
New medical knowledge takes an estimated 17 years to reach routine clinical practice, according to research published in the Journal of the Royal Society of Medicine. Vera Health aims to reduce the time physicians spend searching for and evaluating that knowledge, bringing relevant evidence closer to the moment clinical decisions are made.
“Our mission is to close the gap between what medicine knows and what every patient receives,” said Bennani. “Today, that gap is measured in years. We want it measured in seconds.”
About Vera Health
Vera Health is the search engine that reasons like a clinician, finding and grading evidence before showing the source, strength and limits behind every answer. More than 800,000 clinicians in 190 countries use Vera, which is free for licensed clinicians and trainees, never trains on clinicians’ questions, and is HIPAA and GDPR compliant and SOC 2 Type II certified. Founded in 2024 at Y Combinator by MIT graduates and sons of physicians Taieb Bennani and Maxime Allouch, Vera is headquartered in San Francisco and backed by Threshold Ventures, Gradient, Y Combinator, SV Angel and Mantis VC.
Learn more at verahealth.ai.
¹ Download data: Appark, worldwide App Store and Google Play downloads, June through [September] 2026.
Media Contact
Interdependence
(949) 259-6377 x 225
425709@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vera-health-quietly-became-one-of-the-worlds-most-used-clinical-tools-now-it-has-raised-32-million-to-give-every-clinician-in-the-world-the-best-medical-knowledge-in-seconds-302920905.html
SOURCE Vera Health
Vertical IQ Will Expand Industry Intelligence Platform with Small Business Financial Exchange (SBFE) Small Business Credit Data
CME Group Brazilian Real Futures Set New Daily Volume Record Following Election
Vera Health Quietly Became One of the World’s Most Used Clinical Tools. Now It Has Raised $32 Million to Give Every Clinician in the World the Best Medical Knowledge in Seconds
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoMiami Startup BOB Raises $5.5M To Build An AI-Powered Banking Platform
-
Coin Market4 days agoBitcoin ETFs bleed $635M as October slides back into the red
-
Coin Market4 days agoCysic dangles a 10% bounty, hacker pours loot into Tornado Cash
-
Coin Market4 days agoEthereum delays Glamsterdam Hoodi testnet launch over security risks
-
Coin Market4 days agoMalaysia, Thailand join Singapore’s cross-border stablecoin push
-
Technology4 days agoKin Becomes First U.S. Home Insurer to Enable WebMCP for AI Shopping
-
Coin Market5 days agoWinklevoss PAC moves into Texas Senate race with $81K ad buy
-
Technology5 days agoLunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
